151
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America

, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1919-1929 | Published online: 06 Aug 2020

References

  • Chronic Obstructive Pulmonary Disease (COPD) in the Americas. 2014.
  • Global Intitiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. 2019 Report. Accessed 136 2019.
  • FaganelloMM Factors associated with occurrence of exacerbations in patients with COPD. Available from: https://repositorio.unesp.br/handle/11449/102611: Universidade Estadual Paulista, Faculdade de Medicina de Botucatu 2007.
  • Montes de OcaaM, López VarelabMV, AcuñacA, et al. Guía de práctica clínica de la enfermedad pulmonar obstructiva crónica (EPOC) ALAT-2014: preguntas y respuestas. Arch Bronconeumol. 2015;51(8):14. doi:10.1016/j.arbres.2014.11.017
  • WHO. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. 2007; 18 June. 2019 Accessed 186 2019.
  • AnthonisenNR, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
  • WedzichaJA, DonaldsonGC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204–1205.14651761
  • Soler-CatalunaJJ, Martinez-GarciaMA, Roman SanchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
  • MiravitllesM, FerrerM, PontA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395. doi:10.1136/thx.2003.00873015115864
  • ViniolC, VogelmeierCF. Exacerbations of COPD. Eur Respir Rev. 2018;27:147. doi:10.1183/16000617.0103-2017
  • Montes de OcaM, TalamoC, HalbertRJ, et al. Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the proyecto latinoamericano de investigacion en obstruccion pulmonar (PLATINO) study. Chest. 2009;136(1):71–78. doi:10.1378/chest.08-208119349388
  • CiapponiA, AlisonL, AgustinaM, DemianG, SilvanaC, EdgardoS. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis. COPD. 2014;11(3):339–350. doi:10.3109/15412555.2013.83647924111903
  • MiravitllesM, JardimJR, ZittoT, RodriguesJE, LopezH. Estudio farmacoeconómico del tratamiento antibiótico de las agudizaciones de la bronquitis crónica y la EPOC en Latinoamérica.[Pharmacoeconomic study of antibiotic therapy for exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in Latin America]. Arch Bronconeumol. 2003;39(12):549–553. Spanish. doi:10.1016/S0300-2896(03)75453-214636491
  • KoblizekV, NovotnaB, ZbozinkovaZ, HejdukK. Diagnosing COPD: advances in training and practice - a systematic review. Adv Med Educ Pract. 2016;7:219–231. doi:10.2147/AMEP.S7697627099544
  • LamprechtB, SorianoJB, StudnickaM, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):15. doi:10.1378/chest.14-2535
  • AlmagroP, SorianoJB. J.B. S. Underdiagnosis in COPD: a battle worth fighting. Lancet Respir Med. 2017;5(5):2. doi:10.1016/S2213-2600(17)30133-927939077
  • MiravitllesM, MayordomoC, ArtesM, Sanchez-AgudoL, NicolauF, SeguJL. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO group. Estudio observacional de la limitacion obstructiva al flujo aEreo. Respir Med. 1999;93(3):173–179. doi:10.1016/S0954-6111(99)90004-510464874
  • AisanovZ, BaiC, BauerleO, et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Int J Chron Obstruct Pulmon Dis. 2012;7:271–282. doi:10.2147/COPD.S2805922563246
  • MiravitllesM, MurioC, Tirado-CondeG, et al. Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis. 2008;3(4):803–814. doi:10.2147/COPD.S425719281096
  • Calle RubioM, Lopez-CamposJL, Soler-CatalunaJJ, et al. Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study. Respir Res. 2017;18(1):200. doi:10.1186/s12931-017-0685-829197415
  • RobertsCM, Lopez-CamposJL, Pozo-RodriguezF, HartlS; European CAt. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax. 2013;68(12):1169–1171. doi:10.1136/thoraxjnl-2013-20346523729193
  • MenezesAM, Perez-PadillaR, JardimJR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881. doi:10.1016/S0140-6736(05)67632-516310554
  • LopardoG, PensottiC, ScapellatoP, et al. Consenso intersociedades para el manejo de infecciones respiratorias: bronquitis aguda Y enfermedad pulmonar obstructiva crónica. Medicina. 2013;73:11.
  • CampbellS, ForbesBA. The clinical microbiology laboratory in the diagnosis of lower respiratory tract infections. J Clin Microbiol. 2011;49(9):1. doi:10.1128/JCM.00789-11
  • LondoñoD, GarcíaOM, CelisC, et al. Guía de práctica clínica basada en la evidencia para la prevención, diagnóstico, tratamiento y seguimiento de la enfermedad pulmonar obstructiva crónica (EPOC) en población adulta. Acta Med Colomb. 2014;39(2):48.
  • Gómez MuñozaJM, Gómez RincónJC, MuniveAA, et al. Guías para la inmunización del adolescente y adulto en Colombia. Documento de actualización, 2016. Infectio. 2016;20(4):19.
  • LundgrenF, MaranhãoB, JardimJR, et al. Doença Pulmonar Obstrutiva Crônica: exacerbação. 2012.
  • SaludS Diagnostico y tratamiento de la enfermedad pulmonar obstructiva, Mexico. 2009.
  • VaronF, Torres-CaroC, Herrera-DiazC, et al. Microbiological characterization of severe exacerbations in Chronic Obstructive Pulmonary Disease (COPD) in patients admitted to the ICU with or without associated pneumonia: a retrospective cross-sectional study. Infectio. 2019;23(4):6. doi:10.22354/in.v23i4.803
  • PaduaJ, Ramirez-VenegasA, Hernandez-ZentenoRJ, Sanchez-RomeroC, Quiñones-FalconiF, Sansores-MartinezRH. P2300 high prevalence of gramnegative enteric bacilli and pseudomonas in mild exacerbation of early stages COPD (GoldI-II). Eur Respir J. 2008;32.
  • Paulin-PradoP, Bautista-FélixN, Velazquez-UncalM, et al. Are viral infections associated to severe exacerbation in Chronic Obstructive Pulmonary Disease (COPD) due to biomass exposure? Am J Respir Crit Care Med. 2016;193:A5187.
  • EchazarretaAL, AriasSJ, Del OlmoR, et al. Prevalence of COPD in 6 urban clusters in Argentina: the EPOC.AR study. Arch Bronconeumol. 2018;54(5):260–269. doi:10.1016/j.arbres.2017.09.01829221827
  • Lopez VarelaMV, Montes de OcaM, ReyA, et al. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: the PUMA study. Respirology. 2016;21(7):1227–1234. doi:10.1111/resp.1283427319305
  • CaballeroA, Torres-DuqueCA, JaramilloC, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133(2):343–349. doi:10.1378/chest.07-136117951621
  • MenezesAM, JardimJR, Perez-PadillaR, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO study in Sao Paulo, Brazil. Cad Saude Publica. 2005;21(5):1565–1573. doi:10.1590/S0102-311X200500050003016158163